Hard to know what to make of this quarterly. Surge in other working capital and staff costs have resulted in slightly negative cashflow. On the flip side PSZ is staring at $80m+ annualised revenues, and this quarterly would only reflect 1 month of purehacking.
Without an explanation its impossible to know what is going on here.
Is all this increase in revenue reflecting an increase in earnings? I hope so. Good thing is PSZ is priced for complete failure at the moment.
People's thoughts?
- Forums
- ASX - By Stock
- ASV
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-2
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ASV (ASX) to my watchlist
|
|||||
Last
2.2¢ |
Change
0.002(10.0%) |
Mkt cap ! $14.51M |
Open | High | Low | Value | Volume |
2.0¢ | 2.2¢ | 2.0¢ | $12.05K | 602.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1125788 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 999999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1125788 | 0.019 |
1 | 155666 | 0.018 |
2 | 302844 | 0.016 |
3 | 963889 | 0.014 |
2 | 242000 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 999999 | 1 |
0.023 | 500000 | 1 |
0.024 | 10000 | 1 |
0.026 | 80000 | 1 |
0.029 | 9000 | 1 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
ASV (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online